Medrobotics Announces Appointment Of Shawn Wery As Vice President of Clinical-Regulatory Affairs

May 11, 2011 - Medrobotics Corporation is pleased to announce the appointment of Shawn Wery to lead the Company's Clinical and Regulatory Affairs worldwide. Mr. Wery was recently promoted to this position after bringing over fifteen years clinical and regulatory experience in both publicly traded medical device companies such as Medtronic, Guidant, Boston Scientific, J&J and most recently at innovative medical device start-up Cyberkinetics.  He has considerable experience managing and developing clinical and regulatory strategies for a diverse range of products including cardiac pacemakers, stents, neurosurgical monitoring, spinal cord regeneration therapeutics and neural prosthesis.  Mr. Wery holds an MS in Exercise Physiology from The University of Michigan where he designed proprietary products and supervised research for the Departments of Gerontology and Thoracic Surgery.

Mr. Wery's appointment coincides with the Company's near term plans of seeking regulatory approval in several countries around the world to commercialize its products.

About Medrobotics

Medrobotics Corporation ( is a privately held company headquartered in Raynham, Massachusetts, that is developing and commercializing the Flex™ System, a robotic assist platform that enables surgeons to gain single-site access and visualization to difficult-to-access anatomical locations. The system provides a precise and stable platform for enhanced visualization, and enables two-handed dexterity with compatible third-party tools having tactile feedback. The Flex™ System is anticipated to be commercially available in 2013.




Medrobotics' Flex® System Honored With One Of Top 100 Annual Best of What's New Awards, Nov. 21, 2014 More

Medrobotics Closes $20 Million Financing: Company Extends its Runway for Commercialization of the Ground-Breaking Flex® System in Otolaryngology, Oct. 20, 2014 More

Medrobotics Announces Launch of the Flex® Retractor, Sept. 18, 2014 More

Surgeons Complete Cancer Surgery with Medrobotics’ Flex® System in Front of a Live Audience at Head and Neck Surgical Course at University Hospital of Marburg, Sept. 1, 2014 More

Surgeons of the University Hospital Essen Complete World’s First Robotic-Assisted Cancer Surgery with Medrobotics' Flex® System, July 20, 2014 More

University Hospital Dinant Godinne-UCL Namur Completes World’s First Robotic-Assisted Surgery with Medrobotics‘ Flex® System, June 18, 2014 More

Medrobotics Closes $26 Million Series E Financing, May 13, 2014 More

Medrobotics Corporation Receives CE Mark for the Flex® System, Mar. 18, 2014 More

Medrobotics Appoints Russell M. Singleton, Ph.D., as Senior Vice-President R&D, Mar. 17, 2014 More

Medrobotics Appoints Thomas F. Patzelt Vice-President Marketing, Jan. 2, 2014 More

Medrobotics Gains ISO 13485: 2003 Certification for the Design, Manufacture, Service and Distribution of the Flex™ System, Nov. 3, 2013 More

Medrobotics Closes On $10 Million Financing From Hercules, March 22, 2013 More

Medrobotics Appoints Richard S. Walsh Vice-President Global Sales, Feb. 4, 2013 More

Medrobotics Completes $33.6 Million Series D Financing: Company Prepares for Commercialization of the Ground-Breaking Flex™ System in Otolaryngology, Dec. 20, 2012

Medrobotics Corporation. ©2014. All rights reserved.   Legal Information  •  Privacy Policy